glp-1 agonist and heart failure Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, Emerging Therapies Efficacy of GLP‐1 receptor agonists
Description
Below is a clinically accurate overview of current FDA-approved GLP-1 receptor agonists in the United States, along with their delivery forms and labeled therapeutic uses
Lund, P
Competing interests The authors declare no conflicts of interest
Med J Bakirkoy
63 However, a large retrospective cohort study did not find differences in the progression to hip and knee OA in patients with obesity who were exposed to GLP-1 agonists compared with those who were not over a 5-year period
Benvenga S, Bartolone L, Squadrito S, Lo Giudice F, Trimarchi F
